https://adisinsight.springer.com/drugs/800087230?error=cookies_not_supported&code=470d48f4-0379-438a-a01c-f45092f2d173
Anti-CD70 chimeric antigen receptor T cell therapy - Hrain Biotechnology - AdisInsight
A chimeric antigen receptor (CAR) T-cell therapy, targeting the CD 70 antigen is being developed by HRAIN Biotechnology using DashCAR T platform for the
chimeric antigen receptorcell therapy